Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Live presentation

Click here to access the replay of the virtual R&D Investor Day on October 15, 2020

Click here to access the replay of the HY Results FY20 management call on September 17, 2020

 

Analyst Coverage
Conferences & Events
Financial calendar

Check the calendar to learn more about our financial results, general shareholders meetings and business reviews.

  • 18/03/2021
    Full Year Results FY20
  • 04/05/2021
    Annual Shareholders Meeting
  • 06/05/2021
    Q1 Business Update FY21
  • 09/09/2021
    Half Year Results & Business Update FY21
  • 14/10/2021
    Q3 Business Update FY21
  • 17/03/2022
    Full Year Results FY21
Corporate governance

Good corporate governance is key to the success of our company. Read more about the Code of Business Conduct, our Board of Directors and Board Committees.

more info

Perspectives magazine & blog

Looking for more background stories or interviews with scientists and partner organizations? Read more articles on our blog Perspectives or download the magazine!

Visit Perspectives blog

Read Perspectives magazine

Investor relations contact

Wouter Piepers
Global Head of Corporate Communications and Investor Relations

Gaston Geenslaan 1
B-3001 Heverlee
Belgium
Tel: +32 (0) 16 75 13 10
Cell: +32 478 33 56 32
wouter.piepers@oxurion.com
IR@oxurion.com